Blogs

Genome Editing

Genome editing technologies have developed in a vertiginous way. These techniques enable scientists to make changes to DNA, leading to changes in physical traits, like eye colour, and disease risk. Scientists use different technologies to do this. These technologies act like scissors, cutting the DNA at a specific spot. Then scientists can remove, add, or replace the DNA where it was cut. The first genome editing technologies were developed in the late 1900s. More recently, a new genome editing tool called CRISPR, invented in 2009, has made it easier than ever to edit DNA. CRISPR is simpler, faster, cheaper, and more accurate than older genome editing methods. Many scientists who perform genome editing now use CRISPR. Genome editing tools have the potential to help treat diseases with a genomic basis, like cystic fibrosis and diabetes. However, treatments are still experimental because the scientific community and policymakers still have to address technical barriers and ethical concerns surrounding genome editing.

Keynote Connect organises biotechnology conference and brings together scientists from academia and biopharma executives, including regulators and ethicists to discuss on recent developments in clinical trials and genome editing tools such as CRISPR/Cas9, biochemistry of genome editing, genome editing to natural genome editing and DNA damage repair processes and ethics of human genome editing. 

The global genome editing/genome engineering market size is projected to reach USD 11.2 billion in 2025 from USD 5.1 billion in 2020, at a CAGR of 17.0 % during the forecast period. Market growth is largely driven by factors such as the availability of government funding and growth in the number of genomics projects. CRISPR accounted for the largest share of the genome editing/genome engineering market, by technology, in 2019. The large share of this segment can be attributed to the ease of use associated with CRISPR. The pharmaceutical companies segment accounted for the largest share of the genome editing/genome engineering market in 2019. The increasing prevalence of infectious diseases and cancer is driving research activities worldwide. This is expected to drive the demand for genome editing in biotechnology & pharmaceutical companies.

Keynote Connect | Medical Conference | Healthcare Workshop | Biotechnology Conference | Accademic Conference | Genome Editing Conference